Janssen COVID-19 vaccine (Johnson & Johnson) questions

i

Up-to-date Information: Up-to-Date Info : To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Janssen COVID-19 vaccine (Johnson & Johnson) questions

Supporting Files Public Domain

May 5, 2021
By National Center for Immunization and Respiratory Diseases (U.S.)

File Language:

English

Details

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)
Description:

Janssen COVID-19 Vaccine (Johnson & Johnson): Effective April 23, 2021, CDC and FDA recommend that use of the Janssen COVID-19 Vaccine resume in the United States. However, women younger than 50 years old especially should be made aware of a rare risk of blood clots with low platelets following vaccination and the availability of other COVID-19 vaccines where this risk has not been observed. Read the CDC/FDA statement.
Content Notes:

About the Vaccine -- Vaccine Supply and Distribution -- Vaccine Schedule and Use -- Vaccine Storage and Handling -- Vaccine Administration.
Subjects:

Ad26COVS1 Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control
Document Type:

Webpage
Name as Subject:

Janssen COVID-19 vaccine ; Janssen COVID-19 vaccine
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:838344f134e1c5e2fc6d681b8746bc4eb7a4ade45de3e2b36bf8587d105dc397
Download URL:

https://stacks.cdc.gov/view/cdc/106621/cdc_106621_DS1.pdf
File Type:

[PDF - 209.71 KB ]

janssen-faqs.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.